BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ResMed Inc. (RMD) Completes Acquisition Of Saime SA


10/19/2005 5:09:48 PM

SAN DIEGO, May 24 /PRNewswire-FirstCall/ -- ResMed Inc today announced that it has completed its acquisition of Saime SA, previously announced on May 5, 2005. ResMed acquired Financiere ACE SAS, the holding company for Saime SA and its affiliates, for an enterprise value of approximately 85 million Euro. ResMed funded the transaction with cash reserves and a five-year secured loan of 50 million Euro from HSBC Bank Australia Limited.

Saime is a leading developer and distributor of ventilation products in France and Germany. With annual revenues of approximately 28 million Euro, the company distributes its products directly in France and Germany and through a network of distributors in Europe and Asia-Pacific.

About ResMed

ResMed is a leading manufacturer of medical equipment for the treatment and management of sleep-disordered breathing and other respiratory disorders. We are dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit http://www.resmed.com/.

ResMed Inc

CONTACT: Hillary Theakston, Director of Investor Relations of ResMedInc, +1-858-746-2610



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES